R&D

Inova Top 10 Newsletter – September 2017

It was a historical month in the field of immuno-oncology and the biopharma industry in general. Last month, we’ve seen back-to-back news about CAR-T therapy, from Gilead Science’s $ 11.9 Billion acquisition of Kite Pharma to the approval of the first CAR-T therapy in the world from Novartis. Meanwhile, we have seen several articles […]

By |September 12th, 2017|Uncategorized|0 Comments

Improving Drug Discovery through Partnerships

By |January 7th, 2015|Uncategorized|Comments Off on Improving Drug Discovery through Partnerships

How Partnering Pays Off: Leveraging External Assets to Boost Pipeline Value

By |July 31st, 2014|Uncategorized|Comments Off on How Partnering Pays Off: Leveraging External Assets to Boost Pipeline Value

How good scouting can beat good R&D: The Cisco vs. Lucent example

By |October 15th, 2013|Uncategorized|Comments Off on How good scouting can beat good R&D: The Cisco vs. Lucent example

Facing high drug R&D costs? Partnering can help

By |August 19th, 2013|Uncategorized|Comments Off on Facing high drug R&D costs? Partnering can help

Bringing Technology and Innovation to the Heart of Biotechnology Manufacturing

By |February 6th, 2013|Uncategorized|Comments Off on Bringing Technology and Innovation to the Heart of Biotechnology Manufacturing